Search research articles
Contact Us
Filters
Showing results (11-20 of 94) with videos related to
Page
of 10
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica
|
March 6, 2012
[Hepatitis E: molecular virology, epidemiology and pathogenesis]
Francisco Rodríguez-Frias, Rosendo Jardi, María Buti
Annals of Hepatology
|
October 12, 2013
Hepatitis E virus: new faces of an old infection
Mar Riveiro-Barciela, Francisco Rodríguez-Frías, María Buti
Gastroenterologia Y Hepatologia
|
May 22, 2012
[Hepatitis E: scale of the problem in Spain]
Mar Riveiro-Barciela, Francisco Rodríguez-Frías, María Buti
United European Gastroenterology Journal
|
December 2, 2023
Management of chronic HBV-HDV patients chronic HBV-HDV infection: A review on new management options
María Buti, Alexia Gonzalez, Mar Riveiro-Barciela, et al.
Pharmacoeconomics
|
January 19, 2013
Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review
María Buti, Itziar Oyagüez, Virginia Lozano, et al.
Cancers
|
April 27, 2024
Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure
Elena Vargas-Accarino, Mónica Higuera, María Buti, et al.
Gastroenterologia Y Hepatologia
|
April 17, 2016
[Cost-effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C: Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis]
María Buti, Raquel Domínguez-Hernández, Itziar Oyagüez, et al.
Gastroenterologia Y Hepatologia
|
April 19, 2015
[Importance of hepatitis B virus screening in hematological patients]
Mar Riveiro-Barciela, Gonzalo Artaza, Pau Abrisqueta, et al.
Annals of Hepatology
|
April 21, 2017
Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B
Itziar Oyagüez, María Buti, Max Brosa, et al.
Expert Review of Anti-Infective Therapy
|
October 24, 2025
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta
Juan Carlos Ruiz-Cobo, Adriana Palom, Mar Riveiro-Barciela, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 94) with videos related to
Sort By:
Page
of 10
Enfermedades Infecciosas Y Microbiologia Clinica
|
March 6, 2012
[Hepatitis E: molecular virology, epidemiology and pathogenesis]
Francisco Rodríguez-Frias, Rosendo Jardi, María Buti
Annals of Hepatology
|
October 12, 2013
Hepatitis E virus: new faces of an old infection
Mar Riveiro-Barciela, Francisco Rodríguez-Frías, María Buti
Gastroenterologia Y Hepatologia
|
May 22, 2012
[Hepatitis E: scale of the problem in Spain]
Mar Riveiro-Barciela, Francisco Rodríguez-Frías, María Buti
United European Gastroenterology Journal
|
December 2, 2023
Management of chronic HBV-HDV patients chronic HBV-HDV infection: A review on new management options
María Buti, Alexia Gonzalez, Mar Riveiro-Barciela, et al.
Pharmacoeconomics
|
January 19, 2013
Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review
María Buti, Itziar Oyagüez, Virginia Lozano, et al.
Cancers
|
April 27, 2024
Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure
Elena Vargas-Accarino, Mónica Higuera, María Buti, et al.
Gastroenterologia Y Hepatologia
|
April 17, 2016
[Cost-effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C: Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis]
María Buti, Raquel Domínguez-Hernández, Itziar Oyagüez, et al.
Gastroenterologia Y Hepatologia
|
April 19, 2015
[Importance of hepatitis B virus screening in hematological patients]
Mar Riveiro-Barciela, Gonzalo Artaza, Pau Abrisqueta, et al.
Annals of Hepatology
|
April 21, 2017
Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B
Itziar Oyagüez, María Buti, Max Brosa, et al.
Expert Review of Anti-Infective Therapy
|
October 24, 2025
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta
Juan Carlos Ruiz-Cobo, Adriana Palom, Mar Riveiro-Barciela, et al.
Page
of 10